Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-03-02 @ 8:17 AM
Study NCT ID:
NCT02039505
Status:
COMPLETED
Last Update Posted:
2019-04-25
First Post:
2014-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis
Sponsor:
Takeda
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MLN0002/CCT-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None